Page M Trotter, Amanda R Merner, Lauren A Ginn, Abigail C Martinez, Ana L Battaglino, Kaitlynn P Craig, Jason Bach, Katherine J Freedberg, Takahiro Soda, Eric A Storch, Gabriel Lázaro-Muñoz, Stacey Pereira
{"title":"导航未来的多基因风险评分:来自儿童和青少年精神病学家的见解。","authors":"Page M Trotter, Amanda R Merner, Lauren A Ginn, Abigail C Martinez, Ana L Battaglino, Kaitlynn P Craig, Jason Bach, Katherine J Freedberg, Takahiro Soda, Eric A Storch, Gabriel Lázaro-Muñoz, Stacey Pereira","doi":"10.1007/s10578-025-01854-y","DOIUrl":null,"url":null,"abstract":"<p><p>Polygenic risk scores (PRS) are a method of calculating genetic risk for polygenic, or multi-gene, disorders. These scores have potential impacts in the realm of child and adolescent psychiatry, given the high prevalence of psychiatric disorders among youth. However, there are concerns about PRS implementation among key stakeholders, namely child and adolescent psychiatrists (CAP). We conducted interviews with 29 U.S.-based CAP to investigate clinician attitudes toward the use of PRS. The data herein correspond to a future scenario we provided CAP in which PRS are accurate and portable to patients of different racial and ethnic backgrounds. We found that CAP envisioned some utility for PRS in regards to clinical surveillance and treatment; however, several desired further research demonstrating that PRS positively impact patient outcomes before they would consider implementing PRS in-clinic. The most cited concern about PRS deployment was the potential for misinterpretation and misuse of PRS on the part of patients, families, corporate entities, and clinicians themselves. CAP emphasized the need for support in the form of testing infrastructure, clinical guidelines, and collaboration with the involvement of PRS experts, when considering PRS applications in the future.</p>","PeriodicalId":10024,"journal":{"name":"Child Psychiatry & Human Development","volume":" ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2025-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12212414/pdf/","citationCount":"0","resultStr":"{\"title\":\"Navigating the Future of Polygenic Risk Scores: Insights from Child and Adolescent Psychiatrists.\",\"authors\":\"Page M Trotter, Amanda R Merner, Lauren A Ginn, Abigail C Martinez, Ana L Battaglino, Kaitlynn P Craig, Jason Bach, Katherine J Freedberg, Takahiro Soda, Eric A Storch, Gabriel Lázaro-Muñoz, Stacey Pereira\",\"doi\":\"10.1007/s10578-025-01854-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Polygenic risk scores (PRS) are a method of calculating genetic risk for polygenic, or multi-gene, disorders. These scores have potential impacts in the realm of child and adolescent psychiatry, given the high prevalence of psychiatric disorders among youth. However, there are concerns about PRS implementation among key stakeholders, namely child and adolescent psychiatrists (CAP). We conducted interviews with 29 U.S.-based CAP to investigate clinician attitudes toward the use of PRS. The data herein correspond to a future scenario we provided CAP in which PRS are accurate and portable to patients of different racial and ethnic backgrounds. We found that CAP envisioned some utility for PRS in regards to clinical surveillance and treatment; however, several desired further research demonstrating that PRS positively impact patient outcomes before they would consider implementing PRS in-clinic. The most cited concern about PRS deployment was the potential for misinterpretation and misuse of PRS on the part of patients, families, corporate entities, and clinicians themselves. CAP emphasized the need for support in the form of testing infrastructure, clinical guidelines, and collaboration with the involvement of PRS experts, when considering PRS applications in the future.</p>\",\"PeriodicalId\":10024,\"journal\":{\"name\":\"Child Psychiatry & Human Development\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2025-05-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12212414/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Child Psychiatry & Human Development\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10578-025-01854-y\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Child Psychiatry & Human Development","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10578-025-01854-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}
Navigating the Future of Polygenic Risk Scores: Insights from Child and Adolescent Psychiatrists.
Polygenic risk scores (PRS) are a method of calculating genetic risk for polygenic, or multi-gene, disorders. These scores have potential impacts in the realm of child and adolescent psychiatry, given the high prevalence of psychiatric disorders among youth. However, there are concerns about PRS implementation among key stakeholders, namely child and adolescent psychiatrists (CAP). We conducted interviews with 29 U.S.-based CAP to investigate clinician attitudes toward the use of PRS. The data herein correspond to a future scenario we provided CAP in which PRS are accurate and portable to patients of different racial and ethnic backgrounds. We found that CAP envisioned some utility for PRS in regards to clinical surveillance and treatment; however, several desired further research demonstrating that PRS positively impact patient outcomes before they would consider implementing PRS in-clinic. The most cited concern about PRS deployment was the potential for misinterpretation and misuse of PRS on the part of patients, families, corporate entities, and clinicians themselves. CAP emphasized the need for support in the form of testing infrastructure, clinical guidelines, and collaboration with the involvement of PRS experts, when considering PRS applications in the future.
期刊介绍:
Child Psychiatry & Human Development is an interdisciplinary international journal serving the groups represented by child and adolescent psychiatry, clinical child/pediatric/family psychology, pediatrics, social science, and human development. The journal publishes research on diagnosis, assessment, treatment, epidemiology, development, advocacy, training, cultural factors, ethics, policy, and professional issues as related to clinical disorders in children, adolescents, and families. The journal publishes peer-reviewed original empirical research in addition to substantive and theoretical reviews.